智通财经APP讯，美瑞健康国际(02327)公布2024年业绩，收益5067.6万港元，同比减少60.81%。公司拥有人应占溢利3248万港元，同比减少20.45%。每股盈利0.79港仙，末期股息每股0.4港仙。
公告称，收益减少主要归因于市况欠佳导致销售建筑材料及健康医疗相关产品销售分别减少3040万港元及3030万港元;及国际贸易销售减少，导致新能源产品采购服务收入减少1980万港元。
溢利减少主要由于健康医疗相关业务及贸易业务的毛利分别减少约2690万港元及2150万港元;及资产减值亏损增加约1630万港元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.